Line-Related Thrombosis: How Long to Anticoagulate After?
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared on LinkedIn:
Important clinical update on catheter-related thrombosis management
As clinicians, we often face questions about anticoagulation duration after catheter removal. The evidence suggests:
- NCCN guidelines recommend a minimum 3-month treatment for thrombosis, particularly in active malignancy
- Emerging evidence shows 1-month regimens may be sufficient in selected cases, with promising outcomes
- Patient-specific factors matter: cancer remission status significantly reduces recurrence risk (2.3%)
Key considerations include balancing thrombosis recurrence (4.8% at 1 year) against major haemorrhage risks (2.8-4.9%)
What’s your experience with anticoagulation duration in these cases? Would love to hear colleagues’ perspectives.”
Read the full review post here.
Review Post: For catheter or line-related thrombosis where removal is necessary, how long should anticoagulation be continued?
Author: Abdul Mannan
Stay informed on all guideline updates with Hemostasis Today.
-
Aug 23, 2025, 16:06Hemophilia Doesn’t Define Me—Skyler Tulley’s 100-Mile Challenge
-
Aug 23, 2025, 08:34Mamas A. Mamas Highlights UK Registry Data on STEMI Mortality and Infarct Size Trends
-
Aug 23, 2025, 08:28Len Valentino Named Researcher of the Year at BDC 2025
-
Aug 23, 2025, 08:26Thomas Reiser Highlights ISTH Pulse Podcast: Geoffrey Barnes Interviews Fionnuala Ní Áinle on Guideline Development
-
Aug 23, 2025, 08:25Flora Peyvandi on Advancements in Complement Inhibition for PNH and Complement-Mediated TMA
-
Aug 23, 2025, 16:30Benjamin Terrier: RCT Shows Rituximab Outperforms Conventional Therapy for Remission Induction in EGPA Annals of Int Med
-
Aug 23, 2025, 08:33British Journal of Haematology – Ferritin and Haemoglobin Recovery Patterns
-
Aug 23, 2025, 08:32Rare Disease Advisor – Hemolytic Disease Challenges in Neonatal Care
-
Aug 23, 2025, 08:27Manuel Monreal: Cancer Site Influences VTE Outcomes
-
Aug 23, 2025, 08:14Talha Badar on Safe Platelet Count for Lumbar Puncture: Are We Being Overcautious?
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!
-
Aug 17, 2025, 07:31Melissa Korn's story: Recognizing Pulmonary Embolism Symptoms Can Save Lives, NBCA